← Back to Treatments
🏅 FDA Orphan Designation

Firdapse

AMIFAMPRIDINE PHOSPHATE

Manufacturer: Catalyst Pharmaceuticals, Inc.

Indicated for:
Lambert-Eaton myasthenic syndromeOrphan

FDA-Approved Indications (1)

Treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults

Indications & Usage

1 INDICATIONS AND USAGE FIRDAPSE ® is indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults and pediatric patients 6 years of age and older. FIRDAPSE is a potassium channel blocker indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults and pediatric patients 6 years of age and older. ( 1 )

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.